Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

NCT05157100 is registered in ClinicalTrials.gov with The Orthopedic Foundation as lead sponsor.

NCT NCT05157100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
Lead sponsor
The Orthopedic Foundation
Phase
Phase 4
Overall status
Completed
Start date
October 19, 2021
Completion date
September 15, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia